Category: Pharmacology & Therapeutics
Keywords: rapid sequence intubation, rocuronium, paralytic, awareness (PubMed Search)
Posted: 10/9/2025 by Alicia Pycraft
Click here to contact Alicia Pycraft
It is estimated that between 2.6% and 3.4% of patients undergoing rapid sequence intubation (RSI) experience awareness with paralysis, with the highest risk observed in patients receiving rocuronium. Several studies have now demonstrated prolonged time to sedation following RSI with long-acting paralytics, including a 2024 single-centered retrospective chart review by Dukes et al., which found that fewer than half of patients in the ICU receiving rocuronium for RSI were administered sedation within 15 minutes of intubation. The following study by Cappuccilli et al. sought to compare differences in sedation practices between the ED and ICUs at the same institution, hypothesizing that patients undergoing RSI in the ED would experience similar delays in sedation to those in the ICU.